Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer

Summary

Current therapies for Stage IV Pancreatic Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV Pancreatic Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV Pancreatic Cancer.

Timeline

Start

1996-04-10

Primary completion

2005-07-18

Completion

2005-07-18

Drugs

Indications